Gibran A.

Gibran A. has a diverse background in corporate development, finance, and market intelligence. Gibran is currently serving as the Principal of Corporate Development & Strategy at Orchestra BioMed, a biomedical innovation company focused on developing therapeutic products for procedure-based medicine. In this role, Gibran is responsible for forging strategic collaborations with medical device companies and driving successful global commercialization of the company's products. Prior to this, Gibran worked as a Senior Associate in Strategic Finance & Market Intelligence at Orchestra BioMed.

Before joining Orchestra BioMed, Gibran gained experience as an Equity Research Associate at Canaccord Genuity- Global Capital Markets, where they conducted research and analysis on various equity products. Gibran also worked as a Sector Analyst at Third Bridge Group Limited, where they specialized in analyzing specific sectors.

Earlier in their career, Gibran served as an Equities & Derivatives Analyst at Bloomberg LP, where they analyzed and monitored equity and derivatives products.

Throughout their career, Gibran has demonstrated a strong background in financial analysis, market intelligence, and strategic collaboration.

Gibran A. attended Cornell University from an unknown start year until 2017, where they completed a Bachelor of Science degree in Applied Economics & Management and Information Science. Prior to their university studies, they attended Pittsford-Mendon High School, without earning a specific degree or field of study. Furthermore, Gibran has obtained certifications such as the SIE, Series 63, and Series 87 from FINRA, but the specific months and years of when they obtained them are unknown.